FDA Issues Rare 2nd Warning Over Sleep Drug Promos
The U.S. Food and Drug Administration on Wednesday released a second warning over the promotion of insomnia drug Doral, saying the marketing skips important safety information and makes it seem like...To view the full article, register now.
Already a subscriber? Click here to view full article